PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,285 | -69.1% | 236 | -44.1% | 0.00% | – |
Q2 2023 | $17,104 | -36.7% | 422 | -24.2% | 0.00% | – |
Q1 2023 | $27,015 | +93.0% | 557 | +54.7% | 0.00% | – |
Q4 2022 | $14,000 | -39.1% | 360 | -21.6% | 0.00% | – |
Q3 2022 | $23,000 | 0.0% | 459 | -21.7% | 0.00% | – |
Q2 2022 | $23,000 | -25.8% | 586 | -29.5% | 0.00% | – |
Q1 2022 | $31,000 | +6.9% | 831 | +11.8% | 0.00% | – |
Q4 2021 | $29,000 | +31.8% | 743 | +24.5% | 0.00% | – |
Q3 2021 | $22,000 | 0.0% | 597 | +13.5% | 0.00% | – |
Q2 2021 | $22,000 | -31.2% | 526 | -20.2% | 0.00% | – |
Q1 2021 | $32,000 | -22.0% | 659 | -2.2% | 0.00% | – |
Q4 2020 | $41,000 | -25.5% | 674 | -43.3% | 0.00% | – |
Q3 2020 | $55,000 | -11.3% | 1,188 | -3.4% | 0.00% | – |
Q2 2020 | $62,000 | +21.6% | 1,230 | +7.8% | 0.00% | – |
Q1 2020 | $51,000 | – | 1,141 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |